LPL Financial
RUBY

LPL Financial’s Rubius Therapeutics, Inc RUBY Stock Holding History

LPL Financial’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39,307
Closed -$6.88K – 4652
2022
Q4 		$6.88K Sell
39,307
-16,990
-30% -$4.64K ﹤0.01% 4434
2022
Q3 		$24K Sell
56,297
-7,544
-12% -$5.66K ﹤0.01% 4310
2022
Q2 		$54K Buy
63,841
+13,689
+27% +$23K ﹤0.01% 4227
2022
Q1 		$276K Buy
50,152
+21,422
+75% +$136K ﹤0.01% 3628
2021
Q4 		$278K Buy
28,730
+513
+2% +$7.11K ﹤0.01% 3735
2021
Q3 		$505K Sell
28,217
-7,628
-21% -$166K ﹤0.01% 3202
2021
Q2 		$875K Sell
35,845
-8,330
-19% -$208K ﹤0.01% 2678
2021
Q1 		$1.17M Sell
44,175
-2,425
-5% -$35.4K ﹤0.01% 2259
2020
Q4 		$354K Buy
46,600
+6,000
+15% +$35.6K ﹤0.01% 3076
2020
Q3 		$203K Buy
40,600
+5,495
+16% +$29.1K ﹤0.01% 3192
2020
Q2 		$210K Buy
35,105
+3,226
+10% +$19K ﹤0.01% 3097
2020
Q1 		$142K Buy
31,879
+9,953
+45% +$73.9K ﹤0.01% 2913
2019
Q4 		$208K Buy
21,926
+4,361
+25% +$42.2K ﹤0.01% 3079
2019
Q3 		$138K Buy
17,565
+6,970
+66% +$81.2K ﹤0.01% 3110
2019
Q2 		$167K Sell
10,595
-2,720
-20% -$43.9K ﹤0.01% 3073
2019
Q1 		$241K Buy
13,315
+3,220
+32% +$49.4K ﹤0.01% 2810
2018
Q4 		$162K Buy
+10,095
New +$184K ﹤0.01% 2871

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

LPL Financial's RUBY Position: Q1 2023 in Review

LPL Financial sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 39,307 shares — an estimated $6.88K sold.

LPL Financial first reported a position in RUBY in Q4 2018 and held it in 17 quarters. The position peaked at $1.17M in Q1 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • LPL Financial reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 39,307 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $6.88K.
  • LPL Financial first reported a position in Rubius Therapeutics, Inc in Q4 2018 and held it in 17 quarters.
  • LPL Financial's Rubius Therapeutics, Inc position peaked at $1.17M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.